# Hillstream BioPharma Inc. (HILS)

Source: https://www.quantisnow.com/company/HILS
Generated: 2026-11-11T08:03:36.102Z

- Ticker: HILS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2022
- Website: https://www.hillstreambio.com

## About

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar; IC50 against PI3K-delta and HDAC6, which is also known to downregulate; c-myc, a cancer drug target; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor necrosis factor-alpha gene into cancer cells. The company was incorporated in 2019 and is based in Bridgewater, New Jersey.

## Latest HILS news and filings

- 2024-02-14 21:00 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Hillstream BioPharma Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-hillstream-biopharma-inc-amendment-5262729)
- 2024-02-08 21:05 UTC [SEC Form 8-K] [Hillstream BioPharma Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/hillstream-biopharma-inc-filed-sec-form-8-k-other-events-5241658)
- 2023-12-18 15:04 UTC [Insider Buy] [Milby Randy bought $14,587 worth of shares (29,000 units at $0.50), increasing direct ownership by 23% to 156,517 units (SEC Form 4)](https://www.quantisnow.com/insight/milby-randy-bought-14587-worth-of-shares-29000-units-at-5142748)
- 2023-12-12 21:15 UTC [SEC Form 8-K] [Hillstream BioPharma Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/hillstream-biopharma-inc-filed-sec-form-8-k-other-events-5133093)
- 2023-12-11 11:15 UTC [SEC Form 8-K] [Hillstream BioPharma Inc. filed SEC Form 8-K: Other Events (Amendment)](https://www.quantisnow.com/insight/hillstream-biopharma-inc-filed-sec-form-8-k-other-events-amendment-5128675)
- 2023-12-08 12:31 UTC [SEC Form 8-K] [Hillstream BioPharma Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/hillstream-biopharma-inc-filed-sec-form-8-k-other-events-5126719)
- 2023-12-07 21:00 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-hillstream-biopharma-inc-5125105)
- 2023-12-07 01:13 UTC [SEC Form 8-K] [Hillstream BioPharma Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/hillstream-biopharma-inc-filed-sec-form-8-k-regulation-fd-disclosure-5123650)
- 2023-12-04 21:15 UTC [Insider Buy] [Milby Randy bought $10,000 worth of shares (10,000 units at $1.00), increasing direct ownership by 9% to 127,517 units (SEC Form 4)](https://www.quantisnow.com/insight/milby-randy-bought-10000-worth-of-shares-10000-units-at-5116680)
- 2023-11-28 23:35 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-hillstream-biopharma-inc-5107508)
- 2023-11-28 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-hillstream-biopharma-inc-5105199)
- 2023-11-27 21:05 UTC [SEC Form 8-K] [Hillstream BioPharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/hillstream-biopharma-inc-filed-sec-form-8-k-other-events-financial-5104412)
- 2023-11-17 22:24 UTC [SEC Form FWP] [SEC Form FWP filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-fwp-filed-by-hillstream-biopharma-inc-5093988)
- 2023-11-17 21:22 UTC [SEC Form S-1] [SEC Form S-1/A filed by Hillstream BioPharma Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-1a-filed-by-hillstream-biopharma-inc-amendment-5093380)
- 2023-11-17 21:05 UTC [SEC Form 8-K] [Hillstream BioPharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/hillstream-biopharma-inc-filed-sec-form-8-k-other-events-financial-5093095)
- 2023-11-16 21:05 UTC [SEC Form 8-K] [SEC Form 8-K filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-hillstream-biopharma-inc-5090357)
- 2023-11-10 00:55 UTC [SEC Form 4] [SEC Form 4 filed by Bui Lynne A.](https://www.quantisnow.com/insight/sec-form-4-filed-by-bui-lynne-a-5076681)
- 2023-11-10 00:52 UTC [SEC Form 4] [SEC Form 4 filed by Appajosyula Sireesh](https://www.quantisnow.com/insight/sec-form-4-filed-by-appajosyula-sireesh-5076677)
- 2023-11-10 00:51 UTC [SEC Form 4] [SEC Form 4 filed by Anderson Kelly](https://www.quantisnow.com/insight/sec-form-4-filed-by-anderson-kelly-5076676)
- 2023-11-10 00:48 UTC [SEC Form 4] [SEC Form 4 filed by Mazur Leonard L](https://www.quantisnow.com/insight/sec-form-4-filed-by-mazur-leonard-l-5076675)
- 2023-11-07 22:02 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-hillstream-biopharma-inc-5067111)
- 2023-11-07 21:10 UTC [SEC Form 8-K] [Hillstream BioPharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/hillstream-biopharma-inc-filed-sec-form-8-k-entry-into-a-5066167)
- 2023-11-07 17:29 UTC [SEC Form DEL AM filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-del-am-filed-by-hillstream-biopharma-inc-5065226)
- 2023-11-06 22:12 UTC [SEC Form S-1] [SEC Form S-1 filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-hillstream-biopharma-inc-5062939)
- 2023-11-02 20:05 UTC [SEC Form S-8] [SEC Form S-8 filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-hillstream-biopharma-inc-5055197)
- 2023-10-24 20:15 UTC [SEC Form 8-K] [Hillstream BioPharma Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/hillstream-biopharma-inc-filed-sec-form-8-k-submission-of-matters-5035454)
- 2023-09-29 20:05 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-hillstream-biopharma-inc-4994982)
- 2023-09-25 20:15 UTC [SEC Form 8-K] [Hillstream BioPharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/hillstream-biopharma-inc-filed-sec-form-8-k-amendments-to-articles-4986563)
- 2023-09-22 13:06 UTC [Market Chatter] [Hillstream BioPharma Progressing Towards Acquiring Clinical Stage Asset And Announces Corporate Name Change To Tharimmune; Stock To Trade On Nasdaq Under "THAR" Effective Sept. 25](https://www.quantisnow.com/insight/hillstream-biopharma-progressing-towards-acquiring-clinical-stage-asset-and-announces-4983905)
- 2023-09-22 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-4983902)
- 2023-09-22 12:30 UTC [Hillstream BioPharma Progressing Towards Acquiring Clinical Stage Asset and Announces Corporate Name Change to Tharimmune, Inc.](https://www.quantisnow.com/insight/hillstream-biopharma-progressing-towards-acquiring-clinical-stage-asset-and-announces-4983893)
- 2023-09-12 12:30 UTC [SEC Form 8-K] [Hillstream BioPharma Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/hillstream-biopharma-inc-filed-sec-form-8-k-regulation-fd-disclosure-4965683)
- 2023-09-11 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-intraday-session-4963938)
- 2023-09-11 15:54 UTC [Market Chatter] [Hillstream Enters Into An Exclusive Option Agreement To Acquire A Clinical Stage Asset For Chronic Pruritis; Terms Not Disclosed](https://www.quantisnow.com/insight/hillstream-enters-into-an-exclusive-option-agreement-to-acquire-a-4963760)
- 2023-09-11 15:51 UTC [Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic Pruritis](https://www.quantisnow.com/insight/hillstream-enters-into-an-exclusive-option-agreement-to-acquire-a-4963756)
- 2023-09-08 18:30 UTC [Conference Announcement] [Hillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13](https://www.quantisnow.com/insight/hillstream-biopharma-to-present-at-hc-wainwright-25th-annual-global-4961568)
- 2023-08-31 12:13 UTC [Market Insight] [Why Okta Shares Are Trading Higher By 11%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-okta-shares-are-trading-higher-by-11-here-are-4946890)
- 2023-08-30 21:22 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-hillstream-biopharma-inc-4945992)
- 2023-08-22 17:51 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Tuesday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-tuesday-4927865)
- 2023-08-18 21:15 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Hillstream BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-hillstream-biopharma-inc-4918430)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/HILS
- Earnings history: https://www.quantisnow.com/earnings/HILS
- Dividend history: https://www.quantisnow.com/dividends/HILS
- Insider transactions: https://www.quantisnow.com/insiders/HILS
- Options chain: https://www.quantisnow.com/options/HILS
- SEC 8-K filings only: https://www.quantisnow.com/company/HILS/8-k
- RSS and alerts for HILS: https://www.quantisnow.com/docs/rss-feeds.md